Results 111 to 120 of about 18,363 (193)

Is anti-cholinesterase therapy of Alzheimer's disease delaying progression? [PDF]

, 2018
During the last decade, a systematic effort to develop a pharmacological treatment for Alzheimer's disease (AD) resulted in three drugs being registered for the first time in the US and Europe.
Giacobini, E.
core  

In Silico Profiling of Phytochemicals for Modulating Amyloid Beta-Mediated Immune Regulation and Neuroinflammation in Alzheimer's Disease. [PDF]

ACS Omega
Kalidass B, Kodiveri Muthukaliannan G.
europepmc   +1 more source

Design and Physicochemical Characterization of Hybrid PLGA-Curcumin/Carbon Dot Nanoparticles for Sustained Galantamine Release: A Proof-of-Concept Study. [PDF]

Biomolecules
Samiotaki C, Nanaki S, Bikiaris RE, Christodoulou E, Kyzas GZ, Barmpalexis P, Bikiaris DN.   +6 more
europepmc   +1 more source

Antiglycative Properties of Anti-Dementia Drugs-In Vitro, In Silico Studies and a Systematic Literature Review. [PDF]

Antioxidants (Basel)
Orlof W, Ladny JR, Michalak D, Zendzian-Piotrowska M, Zalewska A, Maciejczyk M.   +5 more
europepmc   +1 more source

Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]

Alzheimers Res Ther
Chen C, Mo M, Åkerman M, Garcia-Ptacek S, Xu H, Eriksdotter M.   +5 more
europepmc   +1 more source

Structural and Mechanistic Insights into Dual Cholinesterase Inhibition by Marine Phytohormones. [PDF]

Mar Drugs
Youn K, Soriano LM, Jun M.
europepmc   +1 more source

Medicinal compounds and biotechnology of Amaryllidaceae alkaloids in <i>Lycoris radiata</i>. [PDF]

Front Plant Sci
Chen JX, Zheng J, Cai YM, Xu JX, Sun Y, Yang Z, Yang F, Chen MX, Chen Y, Li QZ.   +9 more
europepmc   +1 more source

Pharmacological aspects of galantamine for the treatment of Alzheimer's disease [PDF]

, 2017
Kim, Jae Kwang, Park, Sang Un
core   +1 more source

Differential cognitive enhancer effects of acetylcholinesterase inhibitors and memantine on age-related deficits in vigilance and sustained attention: a preclinical validation study. [PDF]

Behav Brain Funct
Bali ZK, Bruszt N, Göntér K, Hernádi I.   +3 more
europepmc   +1 more source

Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]

J Alzheimers Dis
Heo RJ, Negida A, Barrett MJ, Chrenka EA, Bayram E, Kane JPM, Werner AM, Rossom RC, Wyman-Chick KA.   +8 more
europepmc   +1 more source